Due to the effect of oestrogens on lactotroph proliferation and hyperplasia, case reports and small case series have explored use of selective oestrogen receptor modulators and aromatase inhibitors for DA resistant prolactinomas, but the results of these studies are not conclusive [109]. Here, CYP19A1 is linked to prolactin-producing pituitary gland adenoma.